GlaxoSmithKline Pharmaceuticals Limited — Others, 06-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

GlaxoSmithKline Pharmaceuticals Limited has provided a certificate in accordance with SEBI regulations for the quarter ended 31st December 2024, confirming the processing of securities for dematerialization. The company received securities from depository participants, which have been verified, listed on stock exchanges, and properly recorded in the register of members. This update reflects the company’s adherence to regulatory compliance and efficient management of its securities operations. From an investor perspective, this proactive approach can foster a positive outlook, indicating the company's commitment to maintaining robust governance and operational efficiency.